Horizon Therapeutics Public Ltd Co

TRUIST FINANCIAL CORP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

1,885

Value ($000)

218

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	218	0.0%	1,885	9/30/2023
2023 Q2	8/1/2023	285	0.0%	2,770	6/30/2023
2023 Q1	5/5/2023	790	0.0%	7,239	3/31/2023
2022 Q4	2/17/2023	7,802	0.0%	68,560	12/31/2022
2022 Q3	10/26/2022	5,345	0.0%	86,365	9/30/2022
2022 Q2	7/22/2022	6,600	0.0%	82,757	6/30/2022
2022 Q1	4/22/2022	9,941	0.0%	94,489	3/31/2022
2021 Q4	2/14/2022	9,617	0.0%	89,248	12/31/2021
2021 Q3	11/5/2021	9,547	0.0%	87,162	9/30/2021
2021 Q2	8/16/2021	7,915	0.0%	84,527	6/30/2021
2021 Q1	5/17/2021	7,352	0.0%	79,891	3/31/2021
2020 Q4	11/19/2021	3,626	0.0%	49,563	12/31/2020
2020 Q3	11/5/2021	848	0.0%	10,925	9/30/2020
2020 Q2	11/16/2021	792	0.0%	14,268	6/30/2020
2020 Q1	11/5/2021	305	0.0%	10,324	3/31/2020
2019 Q4	11/16/2021	366	0.0%	10,129	12/31/2019